The latest addition to the Allergan body contouring portfolio of products, the CoolSculpting CoolTone, has received FDA clearance for improvement of abdominal tone, strengthening of the abdominal muscles, and development for a firmer abdomen.
Allergan's $2.4 billion dollar deal to acquire medical and cooling technology company ZELTIQ Aesthetics has successfully been completed, according to an announcement by the global pharmaceutical company.
Global pharmaceutical company Allergan has received approval from the US Food and Drug Administration (FDA) to market the Natrelle Inspira Cohesive breast implants
Global pharmaceutical company Allergan has announced key future growth drivers for its medical aesthetics portfolio at its first ever Medical Aesthetics Analyst Day this month.
The non-surgical fat reduction treatment CoolSculpting is celebrating 10 years since receiving market approval in 30 countries on September 12.
The US Food and Drug Administration (FDA) has changed the microneedling device classification for aesthetic use to a class II, rather than the automatic class III assignment.
Global pharmaceutical company Allergan has received a ‘positive opinion’ from the Swedish Medical Products Agency (MPA) for BELKYRA.
Global pharmaceutical company Allergan is set to purchase medical and cooling technology company ZELTIQ Aesthetics for US $56.50 per share.
The Food and Drug Administration (FDA) has cleared the CustomFlex Artificial in the US, a prosthetic iris that is surgically implanted to treat adults and children whose iris is damaged or missing due to aniridia (a congenital condition) or other damages to the area.
A survey has suggested that 47% of adults are bothered by the appearance of the area under their chin.